Skip to main content
Signal8
Seror Jasmine profile photo

Jasmine Seror

CIK: 0002120241

Transaction Breakdown

Open Market Buys (P)0

High conviction signal

Open Market Sales (S)0

Position reduction

Option Exercises (M)0

Derivative conversions

Awards (A)0

Compensation grants

Other (G, F, J, C, D, …)0

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CollPlant Biotechnologies Ltd logo
CLGN

CollPlant Biotechnologies Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (0 total)

1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.

0-0 of 0

Jasmine Seror files insider reports with the SEC as VP Product Development of CollPlant Biotechnologies Ltd (CLGN).

About Seror Jasmine

Seror Jasmine (SEC CIK 0002120241) files insider reports with the SEC as VP Product Development of CollPlant Biotechnologies Ltd (CLGN).

Signal8 holds 1 ownership filing by Seror Jasmine, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.

The business address on Seror Jasmine's filings is in REHOVOT.

Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)

How to read Form 4 transaction codes